Bristol/Pfizer clot preventer delayed in U.S
(Reuters) - A closely watched blood clot preventer from Bristol-Myers Squibb Co and Pfizer Inc has failed to win approval from U.S. health regulators, the companies said on Monday. Investors have been awaiting a decision on the drug, Eliquis, by the Food And Drug Administration by the end of the month. The FDA notification did not require the companies to complete any new studies, the companies said, which could mean only a short delay before the drug wins approval. Rather, the agency wants more information on data management and verification from a key clinical trial supporting the medicine. ... read more..
source:http://yhoo.it/MmEDll
3 comments:
Attractive, post. I just stumbled upon Your weblog and wanted to say that I have liked browsing your blog posts. After all, I will surely subscribe to your feed, and I hope you will write again soon! viagra online canadian pharmacy
Thanks for sharing the best information and suggestions, it is very nice and very useful to us. I appreciate the work that you have shared in this post. Keep sharing these types of articles here.https://www.90daymeds.com/product/lantus-insulin-vial/
I'm really inspired together with your writing skills and also with the layout for your weblog. Thanks for sharing this blog here. Allied Health Careers in Texas
Post a Comment